
Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries, a move hailed as a potential gamechanger in the fight against the AIDS epidemic.
Trending
- Beauty and the Beast 2017 – review, facts and cast
- The Business of the New York Knicks
- This new Hema skirt is going to pop up everywhere this summer
- Universal, UK government commit to £7.3bn investment for Universal United Kingdom Resort theme park, first in Europe
- ‘Ons product maakt de man mooier’
- ACE Eddie Awards 2027 Date, Venue & Voting Timeline Set
- Russia and Saudi Arabia draw closer amid OPEC upheaval
- Marcia Lucas, Oscar-Winning ‘Star Wars’ Editor, Dies at 80
